These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [A new board for the judgement of drug advertising]. Lakartidningen; 1969 Aug; 66(35):3442-4. PubMed ID: 5821538 [No Abstract] [Full Text] [Related]
45. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003. Cowden AL; Katz KA Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900 [TBL] [Abstract][Full Text] [Related]
46. [Study on the quality of pharmaceutical advertising in a pharmacy in Congo Brazzaville]. Ibiassi JP Med Trop (Mars); 2006 Dec; 66(6):581-2. PubMed ID: 17286026 [TBL] [Abstract][Full Text] [Related]
56. Pharmaceutical advertising revenue and physician organizations: how much is too much? Glassman PA; Hunter-Hayes J; Nakamura T West J Med; 1999 Oct; 171(4):234-8. PubMed ID: 10578674 [TBL] [Abstract][Full Text] [Related]
57. Advertising and psychotropic drugs: the place of myth in ideological reproduction. Chapman S Soc Sci Med Med Psychol Med Sociol; 1979 Nov; 13A(6):751-64. PubMed ID: 538490 [No Abstract] [Full Text] [Related]
58. Drug advertising. Med J Aust; 1989 Jun; 150(11):664-5. PubMed ID: 2725384 [No Abstract] [Full Text] [Related]
59. Drug marketing in the Third World. Hosking G Lancet; 1986 Jul; 2(8499):164. PubMed ID: 2873426 [No Abstract] [Full Text] [Related]
60. Drug promotion. Stryer DB; Bero LA N Engl J Med; 1995 Apr; 332(15):1032; author reply 1033. PubMed ID: 7885416 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]